(Q37755893)

22 August 2017

title

Azithromycin-induced liver injury (English)

1 reference

22 August 2017

0 references

Alissa M Lockwood

1

1 reference

22 August 2017

Sabrina Cole

series ordinal

2

1 reference

22 August 2017

Marina Rabinovich

series ordinal

3

1 reference

22 August 2017

publication date

1 May 2010

1 reference

American Journal of Health-System Pharmacy

22 August 2017

published in

1 reference

22 August 2017

volume

67

1 reference

22 August 2017

issue

10

1 reference

22 August 2017

page(s)

810-814

1 reference

Steroid therapy for a case of severe drug-induced cholestasis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Hepatotoxicity of antimicrobial agents

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Drug-related hepatotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Antimicrobial-associated acute hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Azithromycin-induced intrahepatic cholestasis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Chemical structure of erythromycin and hepatotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Azithromycin-induced hepatoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Hypersensitivity syndrome associated with azithromycin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

A 33-year-old woman with jaundice after azithromycin use.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Azithromycin clinical pharmacokinetics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Subfulminant liver failure and severe hepatotoxicity caused by loratadine use

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Review article: diagnosis and current therapy of Wilson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

A method for estimating the probability of adverse drug reactions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Is the Naranjo Probability Scale Accurate Enough to Ascertain Causality in Drug-Induced Hepatotoxicity?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Tobramycin-induced hepatotoxicity.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080687

31 March 2020

Identifiers

DOI

10.2146/AJHP080687

1 reference

22 August 2017

1 reference